Centene (CNC) Competitors $58.76 -0.34 (-0.58%) (As of 09:33 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUEShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Alignment Healthcare Trupanion Clover Health Investments NeueHealth Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking. Which has more volatility and risk, ELV or CNC? Elevance Health has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Which has stronger valuation & earnings, ELV or CNC? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$171.34B0.54$5.99B$27.4314.49Centene$154.00B0.19$2.70B$5.7610.26 Do insiders & institutionals have more ownership in ELV or CNC? 89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.3% of Centene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ELV or CNC more profitable? Elevance Health has a net margin of 3.68% compared to Centene's net margin of 1.90%. Elevance Health's return on equity of 19.56% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health3.68% 19.56% 7.22% Centene 1.90%13.32%4.32% Does the media refer more to ELV or CNC? In the previous week, Elevance Health had 15 more articles in the media than Centene. MarketBeat recorded 35 mentions for Elevance Health and 20 mentions for Centene. Elevance Health's average media sentiment score of 1.34 beat Centene's score of 0.52 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 30 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Centene 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts recommend ELV or CNC? Elevance Health presently has a consensus price target of $539.20, indicating a potential upside of 35.65%. Centene has a consensus price target of $83.92, indicating a potential upside of 42.00%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.81Centene 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community believe in ELV or CNC? Centene received 180 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.40% of users gave Centene an outperform vote while only 67.26% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformElevance HealthOutperform Votes86367.26% Underperform Votes42032.74% CenteneOutperform Votes104373.40% Underperform Votes37826.60% SummaryElevance Health beats Centene on 14 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$29.84B$68.94B$5.05B$19.87BDividend YieldN/A1.52%5.17%3.54%P/E Ratio10.2622.00125.6942.87Price / Sales0.190.651,179.7818.11Price / Cash6.219.3333.7717.86Price / Book1.224.964.685.52Net Income$2.70B$3.04B$119.54M$986.45M7 Day Performance1.83%1.58%-2.46%-0.22%1 Month Performance-4.71%-2.47%-4.08%0.12%1 Year Performance-18.77%37.50%29.82%23.71% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9487 of 5 stars$58.76-0.6%$83.92+42.8%-18.8%$29.67B$154.00B10.2067,700Analyst RevisionELVElevance Health4.883 of 5 stars$397.48+0.8%$539.20+35.7%-14.6%$92.18B$171.34B14.49104,900Positive NewsCIThe Cigna Group4.9668 of 5 stars$323.39+0.3%$394.64+22.0%+13.7%$89.95B$195.27B30.5172,500Positive NewsHUMHumana4.3897 of 5 stars$294.09+0.0%$315.86+7.4%-41.4%$35.41B$106.37B26.0467,600Analyst RevisionMOHMolina Healthcare4.7872 of 5 stars$294.64+4.3%$367.17+24.6%-17.3%$16.85B$34.07B14.96123,123Analyst RevisionUNHUnitedHealth Group4.9212 of 5 stars$600.50+4.1%$615.53+2.5%+12.2%$552.63B$371.62B39.12440,000Analyst DowngradeAnalyst RevisionPositive NewsOSCROscar Health3.3192 of 5 stars$17.26+1.5%$22.93+32.8%+105.2%$4.27B$5.86B0.002,400ALHCAlignment Healthcare0.9323 of 5 stars$11.91-0.3%$10.33-13.2%+78.6%$2.28B$1.82B0.001,536Gap UpTRUPTrupanion2.2124 of 5 stars$51.82-2.2%$44.67-13.8%+95.0%$2.19B$1.11B-161.941,142Positive NewsCLOVClover Health Investments1.3658 of 5 stars$3.31-1.2%$4.00+20.8%+236.8%$1.66B$2.03B0.00552NEUENeueHealth3.5078 of 5 stars$4.95+0.2%$8.00+61.6%N/A$40.99M$1.16B-0.101,252 Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives ALHC Alternatives TRUP Alternatives CLOV Alternatives NEUE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
